STOCK TITAN

Monthly information related to total number of voting rights and shares composing the share capital _July 31, 2022

Voting Rights Update: As of July 31, 2022, Erytech Pharma reported a total of 31,018,553 shares in its capital.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

Rhea-AI Summary

Voting Rights Update: As of July 31, 2022, Erytech Pharma reported a total of 31,018,553 shares in its capital. The gross voting rights stood at 32,521,126, while net voting rights were recorded at 32,518,626. This data is crucial as it provides insights into shareholder voting power and potential influence on company decisions. The figures reflect a stable share count with consistent voting rights, ensuring transparency in governance.

Loading...
Loading translation...

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google


                Monthly information related to total number of voting rights and shares composing the share capital _July 31, 2022.

Article 223-16 of general regulation of French Autorité des Marchés Financiers
Lyon – France


Listing markets:
Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) &
Nasdaq Global Select Market in the United-States (Symbol : ERYP)
Website : www.erytech.com

DateTotal of shares composing the share capitalTotal of brut (1) voting rights

Total of net (2) voting rights

December 31, 202131 018 55332 518 33932 515 839
January 31, 202231 018 55332 518 33932 515 839
February 28, 202231 018 55332 518 54732 516 047
March 31, 202231 018 55332 518 54732 516 047
April 30, 202231 018 55332 518 54732 516 047
May 31, 202231 018 55332 518 54732 516 047
June 30, 202231 018 55332 520 10732 517 607
July 31, 202231 018 55332 521 12632 518 626

(1)   Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
(2)   Without treasury shares.

Attachment


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What are the total voting rights for ERPY as of July 31, 2022?

As of July 31, 2022, the total voting rights for ERPY were 32,521,126.

How many shares compose the share capital for ERPY?

Erytech Pharma's share capital comprises 31,018,553 shares.

What is the difference between gross and net voting rights for ERPY?

The gross voting rights for ERPY are 32,521,126, while the net voting rights are 32,518,626, indicating minimal treasury shares.

Keep reading